Tumor microenvironment mimicking devices and methods
A 3D cell culture device replicates the tumor microenvironment to study tumor progression and metastasis, overcoming limitations of existing in vitro and in vivo methods by isolating aggressive cancer cell subpopulations and identifying therapeutic targets.
Patent Information
- Application Number
- JP2024527372
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-15
- Filing Date
- 2022-11-14
- Publication Date
- 2024-11-29
AI Technical Summary
Current in vitro methods for studying tumor progression and metastasis lack the ability to accurately mimic the complex tumor microenvironment, leading to difficulties in understanding genetic and transcriptional changes associated with increased tumor aggressiveness, and existing in vivo models are time-consuming and expensive.
A 3D cell culture device that replicates the in vivo tumor microenvironment by creating stable oxygen and nutrient gradients, allowing for the study of tumor cell migration and invasion, and enabling the isolation of aggressive cancer cell subpopulations.
The device provides a physiologically relevant environment for studying tumor progression, allowing for the isolation of aggressive cancer cell subpopulations and facilitating the identification of therapeutic targets, early diagnosis, and personalized medicine through precise replication of genetic and transcriptional changes.
Smart Images

Figure 2024544361000001_ABST
Abstract
Description
[Technical field]
[0001] The present disclosure relates generally to devices and in vitro methods for investigating tumor progression, particularly with respect to tumor cell proliferation, metabolic activity, 3D migration and invasion, in vitro isolation of cancer cell subpopulations, and changes in gene expression that lead to increased tumor aggressiveness.
[0002] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of U.S. Provisional Application No. 63 / 279,314, filed November 15, 2021, which is incorporated by reference herein in its entirety. [Background technology]
[0003] The present disclosure relates generally to tumor microenvironment mimicking ("TMM") devices, and more particularly to TMM devices and in vitro methods for investigating tumor progression, particularly with respect to tumor cell proliferation, metabolic activity, 3D migration and invasion, and changes in gene expression that lead to increased tumor aggressiveness. Further, the present disclosure relates to devices and in vitro methods for investigating metastatic potential, cellular interactions, cellular response to drugs or compounds, and particularly cellular response in a setting that replicates the tumor 3D microenvironment of solid tumors in vitro. Further, the present disclosure relates to TMM devices and in vitro methods that allow for the generation, isolation, and characterization of tumor cell subpopulations with more aggressive characteristics including higher metastatic potential, gene expression changes, epigenetic modifications, and metabolic changes involved in tumor progression.
[0004] The stepwise progression of human cancer is well documented and clinically recognized. Premalignant lesions, such as dysplasia and hyperplasia, are detected in various organs before the appearance of fully malignant invasive tumors. Premalignant lesions are caused either by genetic mutations inducing monoclonal expansion of cells or by environmental factors, such as viral infection. Genetic mutations then accumulate in one (or some) of the premalignant cells, and these cells are transformed into malignant cells of clonal origin, giving rise to the primary tumor. In the initial stages, the tumor cells proliferate and the primary tumor expands. However, at this stage, the cancer cells are neither invasive nor metastatic. Later, through the accumulation of genetic mutations, new clones develop within the cancer cell population, leading to the acquisition of traits that allow invasion and metastasis. Thus, cells in primary tumors are phenotypically and biologically heterogeneous, and only a subset of cells in primary tumors acquires changes at the genomic level, resulting in different transcriptome signatures that enable them to be invasive and metastatic, which is rooted in differences in gene expression. Highly metastatic cells typically have more frequent genomic mutations compared to non-metastatic cells that lead to differential gene expression between these two cell populations. These cells selectively produce metastatic tumors in distant organs and are the main cause of death in the majority of cancer patients. Therefore, understanding and mapping genomic and transcriptional genetic changes in cancer cells is crucial, as it not only enhances our understanding of cancer cell progression, but also reveals potential therapeutic targets, enables early diagnosis, and promotes efficient treatment.
[0005] The gold standard for assessing the metastatic potential of tumor cells involves the use of in vivo assays, such as mouse or rat model systems. In vivo assays are more time-consuming and expensive than in vitro methods. Although in vivo models can capture the complexity of the metastatic process in a living system, the study and visualization of the individual steps involved is difficult and requires infrastructure that is not accessible to the majority of research groups. Furthermore, extracting quantitative mechanistic data is typically very challenging and often impossible. Accurately tracking genetic and gene expression changes during tumor progression in animal models is further complicated by the fact that tumors are heterogeneous cell populations and contain a variety of other cells, including normal stromal and inflammatory cells. The presence of these cells often masks genetic and gene expression changes. Similarly, isolation of metastatic tumors and examination of gene expression changes involved in the acquisition of metastatic potential is also complicated by gene expression changes that allow these cells to grow at new distant sites or different organs, and these changes do not necessarily reflect the initial acquisition of metastatic potential. In contrast, in vitro models allow control of most experimental variables and allow quantitative analysis.
[0006] However, existing in vitro methods and assays are characterized by reduced physiological relevance and capture only limited aspects of the tumor microenvironment.Spheroid assay is one example of an in vitro assay.Although spheroid assay is the current standard for in vitro assays, spheroid assay has some limitations.For example, spheroid assay is not compatible with all cell lines, does not have standardized protocols, and has limited ability to mimic tumor microenvironment.
[0007] For each of the above reasons, there is a need for devices and methods that can better mimic the tumor microenvironment in vitro. Summary of the Invention
[0008] The present disclosure includes a reliable, simple, low-cost 3D cell culture device that is easy to use (has an uncomplicated protocol), fast, and provides reproducible results. The design of the TMM device and the method of its setup in the present disclosure allows for the in vitro replication of the in vivo tumor microenvironment. The present TMM device has also been uniquely validated to allow tumor progression to occur and be monitored outside of the animal, a key feature not previously demonstrated for other in vitro assays or devices. The presently disclosed TMM device and in vitro methods can be used to determine whether cells of interest are able to migrate and / or invade within a relevant 3D environment characterized by the presence of oxygen, pH, and nutrient gradients similar to in vivo conditions. The TMM device through its intake restriction and device geometry novelly establishes uniform and stable radial gradients and generates solid stresses through the confinement of tumor cells. In addition, the disclosed TMM device and in vitro method can be used to analyze the effect that environmental factors and cells typically found in the tumor microenvironment, such as cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs), have on cancer cell migration and / or invasion. Furthermore, the disclosed TMM device and in vitro method can be used to study the progression of cancer and its cure. For example, the disclosed TMM device and in vitro method can be used to test anti-cancer drugs or other test compounds on metastatic cancer cells. The disclosed TMM device and in vitro method can also be used to study several aspects of cancer, such as cell-cell interactions, metastasis, extravasation, mechanical stimuli, ECM stiffness, the effect of cancer-associated fibroblasts, the metabolic activity of cancer cells, and the effect of different extracellular matrix components. Furthermore, the disclosed TMM device and in vitro method can be used for the isolation of heterogeneous cancer cell populations with higher metastatic potential compared to parental cell lines, which can be further analyzed to enhance the understanding of the molecular mechanisms of metastasis, which can provide novel information, yield new therapeutic targets, enable early diagnosis, and facilitate treatment design.The disclosed TMM device and in vitro methods replicate the tumor microenvironment with such precision that cell populations introduced into the TMM device and exposed to its environmental stressors uniquely exhibit increased aggressiveness, as experimentally validated in preclinical in vivo studies in mice, as well as increased expression of known cancer genes and downregulation of tumor suppressor genes when compared to the parental cell lines.
[0009] The disclosed accurate representation of the in vivo tumor microenvironment provides a powerful tool for studying cancer cells and evaluating potential therapeutics in a physiologically relevant 3D environment. The ability to visualize such processes via real-time microscopy and / or use other techniques to label, identify, or measure cellular responses or effects offers many advantages over traditional cell-based assays and in vivo tumor assessments. Thus, the disclosed devices and in vitro methods can be used for diagnostic and prognostic purposes, research, drug development, drug screening, and personalized medicine.
[0010] In addition, TMM isolated cell lines have the potential to be used to study transcriptional, epigenetic, and metabolic changes involved in increased tumor aggressiveness. Such studies are complicated when performed in vivo, since the establishment of metastatic foci in distant organs may significantly alter the expression profile of tumor cells due to dramatically different conditions at these sites compared to the original tumor location. Such changes are the consequence of metastasis rather than the cause, and often mask the gene expression changes underlying the increased tumor aggressiveness. Thus, TMM isolated cell lines may be an ideal system to understand and map genomic and transcriptional genetic changes in cancer cells. The latter is crucial, since it may not only enhance our understanding of tumor progression, but also lead to the discovery of new therapeutic targets, as well as new diagnostic and prognostic markers that allow early diagnosis and facilitate efficient treatment.
[0011] In a first aspect of the present disclosure, which may be used in conjunction with any other aspect or portion thereof in light of the disclosure described herein and without limiting the disclosure in any way, a TMM device includes a base including a bottom wall and a plurality of base posts extending from the TMM device base, the base posts being separated from one another to form spaces between the base posts, and a lid sized to mate with the base, the lid including a mating wall and a plurality of lid posts extending from the mating wall, the lid posts being separated from one another to form spaces between the base posts, and the lid posts being positioned such that when the lid is mated with the base, the lid can variably cover the spaces between the base posts based on a rotational position of the lid relative to the base.
[0012] In a second aspect of the present disclosure, which may be used with any other aspect or portion thereof, the base post forms a base post ring and the lid post forms a lid post ring, the lid post ring being slightly larger or smaller than the base post ring.
[0013] In a third aspect of the present disclosure, which may be used with any other aspect or portion thereof, the rings are concentric rings or concentric semicircles for TMM devices 110f and 110G, and the inner or outer diameter of the ring on the lid post is sized to slidably engage the outer or inner diameter, respectively, of the ring on the base post.
[0014] In a fourth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the base post and the lid post have at least substantially the same height.
[0015] In a fifth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the base posts are outer base posts, and the base further includes inner core posts extending from the bottom wall, the inner core posts being separated from one another to form spaces between the core posts.
[0016] In a sixth aspect of the present disclosure, which may be used with any of the other aspects or portions thereof, the inner core posts form a ring or semicircle for TMM devices 110f and 110g.
[0017] In a seventh aspect of the present disclosure, which may be used with any other aspect or portion thereof, the lid and base are configured to releasably secure a rotational position of the lid relative to the base.
[0018] In an eighth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the lid is configured to be fastened to the base to releasably fix a rotational position of the lid relative to the base.
[0019] In a ninth aspect of the present disclosure, which may be used with any other aspect or portion thereof, a mating wall extends from a sealing flange of the lid and a peripheral wall extends from a bottom wall of the base, and the sealing flange is configured to be fastened to the peripheral wall to releasably secure a rotational position of the lid relative to the base.
[0020] In a tenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the lid fastening to the base includes multiple threaded openings, each opening corresponding to a different environmental openness setting.
[0021] In an eleventh aspect of the present disclosure, which may be used with any other aspect or portion thereof, one of the lid or base includes a protrusion that snap-fits into one of a number of recesses provided by the other of the lid or base to fix the rotational position of the lid relative to the base.
[0022] In a twelfth aspect of the present disclosure, which may be used with any other aspect or portion thereof, each of the recesses corresponds to a different environmental openness setting.
[0023] In a thirteenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the lid defines at least one medium input opening for injecting medium into a cavity formed between a mating wall of the lid and a bottom wall of the base.
[0024] In a fourteenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the TMM device further includes a core sealer sized to be placed in the lid, the core sealer including at least one plug that blocks the at least one medium input opening.
[0025] In a fifteenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, a mating wall extends from a sealing flange of the lid, the sealing flange defining at least one input hole radially outward of the space and base support posts for receiving culture medium and / or oxygen when the lid is mated with the base.
[0026] In a sixteenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the TMM device includes at least one medium tank sealer for sealing at least one input hole.
[0027] In a seventeenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the TMM device further comprises at least one partition extending radially from the mating wall and perpendicularly from the sealing flange, the at least one partition blocking a space between the mating wall of the lid and the peripheral wall of the base when the lid is mated with the base.
[0028] In an eighteenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the lid includes at least one partition extending from the mating wall, the at least one partition allowing different cells to be placed on the bottom wall of the base, and the at least one partition allowing different cells to be separated.
[0029] In a nineteenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the at least one partition includes two aligned partitions that at least substantially bisect the mating wall.
[0030] In a twentieth aspect of the present disclosure, which may be used in conjunction with any other aspect, or portion thereof, any of the features, functionality, and alternatives described in association with any one or more of Figures 1-27 may be combined with any of the features, functionality, and alternatives described in association with any other aspect of Figures 1-27.
[0031] In a twenty-first aspect of the present disclosure, which may be used with any other aspect or portion thereof, a method of using any of the TMM devices, 10a-10h, 110a, and 110d-110g, to mimic a tumor microenvironment and investigate 3D cell invasion and migration, and / or cellular responses to various environmental factors or other cells.
[0032] In a twenty-second aspect of the present disclosure, which may be used with any other aspect or portion thereof, a method using any of the TMM devices, 10a-10h, 110a, 110d, 110e, 110f, and 110g, to co-culture two or more types of cells and investigate the effect that cellular interactions and / or additional cells may have on tumor cell migration or invasion.
[0033] In a twenty-third aspect of the present disclosure, which may be used with any other aspect or portion thereof, a method of adding growth factors to medium located in a medium tank through an input hole or by introducing cell culture medium outside the invasion zone of the device.
[0034] In a twenty-fourth embodiment of the present disclosure, which may be used with any other embodiment, or portion thereof, a method of introducing a selected extracellular matrix ("ECM") mimic into the invasion zone region of devices 10a-10h, 110a, 110d, 110e, 110f, and 110g via a lateral opening.
[0035] In a twenty-fifth aspect of the present disclosure, which may be used with any other aspect or portion thereof, a method wherein cells within a sample core of TMM devices 10a-10h, 110a, and 110d-110g consume nutrients and oxygen such that the immediate microenvironment within the sample core mimics the necrotic core or hypoxic region of a tumor.
[0036] In a twenty-sixth aspect of the present disclosure, which may be used in conjunction with any other aspect or portion thereof, a method in which an invasion zone region surrounding a sample core provides fewer environmental challenges compared to the sample core region and provides a more desirable microenvironment for cells located within the sample core (i.e., the invasion zone region).
[0037] In a twenty-seventh aspect of the present disclosure, which may be used with any other aspect or portion thereof, a method, wherein zone dividers 46a and 46b extend outwardly from mating wall 42 to provide a physical separation of the wetting zones, thereby creating two or more distinct wetting zones in any one of TMM devices 10a-10g. Further, zone dividers 46a and 46b are disposed on TMM device base (22) and extend from core posts (26) toward outer posts (28) to provide a physical separation of the wetting zones, thereby creating multiple distinct wetting zones in any one of TMM devices 10a-10g, 110a, and 110d-110g.
[0038] In a twenty-eighth aspect of the present disclosure, which may be used with any other aspect or portion thereof, for TMM devices 110f and 110g, the core posts (26) and surrounding posts (28) can extend downward from a base (23) that extends from mating wall 33 to provide physical separation of the core and the infiltration zone.
[0039] In a twenty-ninth aspect of the present disclosure, which may be used with any other aspect or portion thereof, a method in which cells within TMM devices 10a-10h, 110a, and 110d-110g may be visualized using microscopy techniques.
[0040] In a 30th aspect of the present disclosure, which may be used with any other aspect or portion thereof, a method is provided in which a target tumor cell line is added to a sample core of any of TMM devices 10a-10h, 110a, and 110d-110g, and the ability of the target primary tumor cell or tumor cell line to migrate or invade the invasion zone can be evaluated.
[0041] In a thirty-first aspect of the present disclosure, which may be used in conjunction with any other aspect or portion thereof, a method for distinguishing between metastatic and non-metastatic cell lines.
[0042] In a thirty-second aspect of the present disclosure, which may be used in conjunction with any other aspect or portion thereof, a method is provided in which the effect of various environmental factors or cells present within the invasion zone of any of TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g on the ability of a target tumor cell to migrate or invade the surrounding area is analyzed.
[0043] A thirty-third aspect of the present disclosure, which may be used with any other aspect or portion thereof, is a method for evaluating anti-cancer drugs or other test drugs or compounds by analyzing their effect on the ability of tumor cells to migrate or invade the invasion zone of any of TMM devices 10a-10h, 110a, and 110d-110G in the presence of the test drug or compound.
[0044] In a thirty-fourth aspect of the present disclosure, which may be used with any other aspect or portion thereof, a method for isolating a cancer cell subpopulation by introducing tumor cells into a sample core of any of TMM devices 10a-10h, 110a, 110d-110g and allowing them to pass through and exit the invasion zone.
[0045] Thus, an advantage of the present disclosure is to provide a cell culture device that mimics a tumor microenvironment by providing stable growth factor and oxygen gradients through regulated restriction of nutrient and oxygen uptake through the use of outer struts 28. Additionally, the restriction of nutrient and oxygen uptake can be regulated in any of the TMM devices 10a-10g by adjusting the orientation of the lid based on features 58 that affect the positioning of the lid struts 48.
[0046] Another advantage of the present disclosure is that it provides a low-cost device that has a fast and easy protocol for use and results in a simple method for the analysis of cell 3D migration and / or cell invasion, as well as cancer cell progression.
[0047] A further advantage of the present disclosure is to provide devices and methods for analyzing the effectiveness of drugs or compounds on the ability of tumor cells to migrate or invade the surrounding area.
[0048] Yet another advantage of the present disclosure is to provide devices and methods for analyzing the effects of environmental factors, such as oxygen, pressure, cellular nutrients, other cells, chemoattractants, and / or growth factors, on the ability of tumor cells to migrate or invade surrounding areas.
[0049] A further advantage of the present disclosure is that it provides devices and methods for the in vitro isolation of cancer cell subpopulations that exhibit increased aggressiveness in vivo. These isolated aggressive cancer cell subpopulations generated with the TMM device may be used to further study tumor cell transcriptional, epigenetic, and metabolic changes involved in tumor progression and increased tumor aggressiveness.
[0050] A further advantage of the present disclosure is that it provides a device that, through its shape, cell containment, and limited nutrient and oxygen uptake, leads to the establishment of a phenotype resembling a tumor cross-section within two days. The established microtumor cross-section contains typical zones found in human tumors, including a necrotic core, a pre-necrotic zone, a quiescent zone, and a proliferative zone.
[0051] Additional features and advantages are described in and will be apparent from the following detailed description and drawings. The features and advantages described herein are not exhaustive, and in particular many additional features and advantages will be apparent to those skilled in the art in view of the drawings and description. Also, any particular embodiment need not have all of the advantages enumerated herein, and it is expressly contemplated that each advantageous embodiment may be separately claimed. Furthermore, it should be noted that the language used in this specification has been selected primarily for readability and instructional purposes, and is not intended to limit the scope of the inventive subject matter. [Brief description of the drawings]
[0052] [Figure 1A] FIG. 1 is a perspective view of the base of a first embodiment of a tumor microenvironment mimicking ("TMM") device of the present disclosure. [Figure 1B] FIG. 2 is a perspective view of a lid of a first embodiment of a TMM device of the present disclosure. [Figure 1C] FIG. 2 is a perspective view of a core sealer for a first embodiment of a TMM device of the present disclosure. [Figure 1D] FIG. 2 is a perspective view of a second implementation of a base for the first embodiment of the TMM device of the present disclosure. [Figure 1E] FIG. 2 is a perspective view of a second implementation of a lid for the first embodiment of the TMM device of the present disclosure. [Diagram 2] FIG. 1 is a perspective view of an assembled first embodiment of a TMM device of the present disclosure. [Diagram 3] FIG. 1 is an exploded perspective view of a first embodiment of a TMM device of the present disclosure. [Figure 4] FIG. 2 is a first cross-sectional view of an assembled first embodiment of a TMM device of the present disclosure. [Diagram 5] FIG. 2 is a second cross-sectional view of the assembled first embodiment of the TMM device of the present disclosure. [Figure 6] FIG. 2 is a third cross-sectional view of an assembled first embodiment of a TMM device of the present disclosure. [Figure 7A]1A-1D are various top view views of the lid rotated in different positions relative to the base of an assembled first embodiment of a TMM device of the present disclosure. [Figure 7B] 1A-1D are various top view views of the lid rotated in different positions relative to the base of an assembled first embodiment of a TMM device of the present disclosure. [Figure 7C] 1A-1D are various top view views of the lid rotated in different positions relative to the base of an assembled first embodiment of a TMM device of the present disclosure. [Figure 7D] 1A-1D are various top view views of the lid rotated in different positions relative to the base of an assembled first embodiment of a TMM device of the present disclosure. [Figure 7E] 1A-1D are various top view views of the lid rotated in different positions relative to the base of an assembled first embodiment of a TMM device of the present disclosure. [Figure 8A] FIG. 2 is a perspective view of the base of a second embodiment of a TMM device of the present disclosure. [Figure 8B] FIG. 2 is a perspective view of a lid for a second embodiment of a TMM device of the present disclosure. [Figure 8C] FIG. 2 is a perspective view of a core sealer for a second embodiment of a TMM device of the present disclosure. [Figure 8D] FIG. 2 is a perspective view of an assembled second embodiment of a TMM device of the present disclosure. [Figure 8E] FIG. 2 is a first cross-sectional view of an assembled second embodiment of a TMM device of the present disclosure. [Figure 8F] FIG. 2 is a second cross-sectional view of an assembled second embodiment of a TMM device of the present disclosure. [Figure 9A] FIG. 13 is a perspective view of the base of a third embodiment of a TMM device of the present disclosure. [Figure 9B] FIG. 13 is a perspective view of a lid for a third embodiment of a TMM device of the present disclosure. [Figure 9C] FIG. 13 is a perspective view of a core sealer for a third embodiment of a TMM device of the present disclosure. [Figure 9D] FIG. 13 is a perspective view of an assembled third embodiment of a TMM device of the present disclosure. [Figure 9E] FIG. 13 is a first cross-sectional view of an assembled third embodiment of a TMM device of the present disclosure. [Figure 9F] FIG. 2 is a second cross-sectional view of an assembled third embodiment of a TMM device of the present disclosure. [Figure 10A] FIG. 13 is a perspective view of the base of a fourth embodiment of a TMM device of the present disclosure. [Figure 10B] FIG. 13 is a perspective view of a lid for a fourth embodiment of a TMM device of the present disclosure. [Figure 10C] FIG. 13 is a perspective view of a core sealer for a fourth embodiment of the TMM device of the present disclosure. [Figure 10D] FIG. 13 is a perspective view of an assembled fourth embodiment of a TMM device of the present disclosure. [Figure 10E] FIG. 13 is a first cross-sectional view of an assembled fourth embodiment of a TMM device of the present disclosure. [Figure 10F] FIG. 13 is a second cross-sectional view of an assembled fourth embodiment of a TMM device of the present disclosure. [Figure 11A] FIG. 13 is a perspective view of the base of a fifth embodiment of a TMM device of the present disclosure. [Figure 11B] FIG. 13 is a perspective view of a lid for a fifth embodiment of a TMM device of the present disclosure. [Figure 11C] FIG. 13 is a perspective view of a core sealer for a fifth embodiment of the TMM device of the present disclosure. [Figure 11D] FIG. 13 is a perspective view of an assembled fifth embodiment of a TMM device of the present disclosure. [Figure 11E] FIG. 11 is a first cross-sectional view of an assembled fifth embodiment of a TMM device of the present disclosure. [Figure 11F] FIG. 13 is a second cross-sectional view of an assembled fifth embodiment of a TMM device of the present disclosure. [Figure 11G] FIG. 13 is a perspective view of a sixth embodiment of a TMM device of the present disclosure. [Figure 11H] FIG. 13 is a first cross-sectional view of a sixth embodiment of the present disclosure. [Figure 11I] FIG. 13 is a second cross-sectional view of the sixth embodiment of the present disclosure. [Figure 11J] FIG. 13 is a perspective view of a seventh embodiment of a TMM device of the present disclosure. [Figure 11K] FIG. 13 is a perspective view of an eighth embodiment of a TMM device of the present disclosure. [Figure 11L] FIG. 13 is a cross-sectional view of an eighth embodiment of a TMM device of the present disclosure. [Figure 11M] FIG. 13 is an exploded view of a ninth embodiment of a TMM device of the present disclosure. [Figure 11N] FIG. 13 is a perspective view of a ninth embodiment of a TMM device of the present disclosure. [Figure 11O] FIG. 13 is a perspective view of a ninth embodiment of a TMM device of the present disclosure. [Figure 11P] FIG. 13 is a cross-sectional assembly view of a ninth embodiment of a TMM device of the present disclosure. [Figure 12A] FIG. 15 is a perspective view of a tenth embodiment of a TMM device of the present disclosure. [Figure 12B] FIG. 15 is a perspective view of a tenth embodiment of a TMM device of the present disclosure. [Figure 13A] FIG. 1 is a perspective view showing one embodiment of the disclosed method for preparing a microtumor assay protocol. [Figure 13B] FIG. 1 is a perspective view showing one embodiment of the disclosed method for preparing a microtumor assay protocol. [Figure 13C] FIG. 1 is a perspective view showing one embodiment of the disclosed method for preparing a microtumor assay protocol. [Figure 13D] FIG. 1 is a perspective view showing one embodiment of the disclosed method for preparing a microtumor assay protocol. [Figure 13E] FIG. 1 is a perspective view showing one embodiment of the disclosed method for preparing a microtumor assay protocol. [Figure 13F] FIG. 1 is a perspective view showing one embodiment of the disclosed method for preparing a microtumor assay protocol. [Figure 13G] FIG. 1 is a perspective view showing one embodiment of the disclosed method for preparing a microtumor assay protocol. [Figure 14]1 is a graph showing an exemplary invasion of one of six different cell lines using the TMM device of the present disclosure. [Figure 15A] 13 is a confocal fluorescence image showing another example of a co-culture of cancer cells and fibroblast cells cultured via a TMM device of the present disclosure. [Figure 15B] 13 is a confocal fluorescence image showing another example of a co-culture of cancer cells and fibroblast cells cultured via a TMM device of the present disclosure. [Figure 15C] 13 is a confocal fluorescence image showing another example of a co-culture of cancer cells and fibroblast cells cultured via a TMM device of the present disclosure. [Figure 15D] 13 is a confocal fluorescence image showing another example of a co-culture of cancer cells and fibroblast cells cultured via a TMM device of the present disclosure. [Figure 15E] 13 is a confocal fluorescence image showing another example of a co-culture of cancer cells and fibroblast cells cultured via a TMM device of the present disclosure. [Figure 15F] 13 is a confocal fluorescence image showing another example of a co-culture of cancer cells and fibroblast cells cultured via a TMM device of the present disclosure. [Figure 16A] 13A-13D are confocal fluorescence images showing evaluation of the hypoxic gradient generated after 20 days of culture in tumor microenvironment mimicking (TMM) devices. [Figure 16B] 13A-13D are confocal fluorescence images showing evaluation of the hypoxic gradient generated after 20 days of culture in tumor microenvironment mimicking (TMM) devices. [Figure 16C] 13A-13D are confocal images showing evaluation of the hypoxic gradient generated 24 hours after homogenous introduction of cells within the TMM device. [Figure 17] 13 is a confocal image showing a de novo established gradient of growth factors toward the center of a TMM device of the present disclosure. [Figure 18] 13A-13C are confocal images showing a depth-encoded reconstruction of cell invasion from a sample core into the invasion zone of a TMM device of the present disclosure. [Figure 19A] FIG. 15 is a perspective view of an eleventh embodiment of a TMM device of the present disclosure. [Figure 19B]FIG. 15 is a perspective view of an eleventh embodiment of a TMM device of the present disclosure. [Figure 20A] FIG. 23 is a perspective view of a twelfth embodiment of a TMM device of the present disclosure. [Figure 20B] FIG. 23 is a perspective view of a twelfth embodiment of a TMM device of the present disclosure. [Figure 20C] FIG. 23 is a perspective view of a twelfth embodiment of a TMM device of the present disclosure. [Figure 21A] FIG. 12 is a perspective view of a twelfth embodiment of a TMM device of the present disclosure in a multi-well configuration. [Figure 21B] FIG. 12 is a perspective view of a twelfth embodiment of a TMM device of the present disclosure in a multi-well configuration. [Figure 22] 13A-13C are confocal images showing the establishment of a necrotic core by three cell lines using the TMM device of the present disclosure. [Figure 23] 1 is a graph showing the pH gradient established 24 hours after introduction of cells within a TMM device of the present disclosure. [Figure 24A] 1 is a graphical representation of in vivo tumor growth rates (in nude mice) of a parental cancer cell line (MDA-MB-231) and subpopulations, which were generated by isolating cells that passed through and exited the invasion zone of a TMM device of the present disclosure. [Figure 24B] 1 is a table showing the percentage of animals that formed abdominal metastases 9 weeks after injection of nude mice with either the parental cancer cell line (MDA-MB-231) and its subpopulations, which were generated by isolating cells that had passed through and exited the invasion zone of the TMM device of the present disclosure. [Diagram 25] 13A-13C are confocal images showing the conversion of normal fibroblasts to cancer-associated fibroblasts within the invasion zone of a TMM device of the present disclosure. [Figure 26A] 1 is a graphical representation of the assessment of protein levels of known tumor-promoting markers from parental cancer cell lines and their subpopulations generated using the TMM device of the present disclosure. [Figure 26B]1 is a graphical representation of the assessment of protein levels of known tumor-promoting markers from parental cancer cell lines and their subpopulations generated using the TMM device of the present disclosure. [Figure 26C] 1 is a graphical representation of the assessment of protein levels of known tumor-promoting markers from parental cancer cell lines and their subpopulations generated using the TMM device of the present disclosure. [Figure 27A] FIG. 13 is a perspective view of a thirteenth embodiment of a TMM device of the present disclosure as a two-layer multiwell insert. [Figure 27B] FIG. 13 is a perspective view of a thirteenth embodiment of a TMM device of the present disclosure as a two-layer multiwell insert. [Figure 27C] FIG. 13 is a perspective view of a thirteenth embodiment of a TMM device of the present disclosure as a two-layer multiwell insert. [Figure 27D] FIG. 13 is a perspective view of a thirteenth embodiment of a TMM device of the present disclosure as a two-layer multiwell insert. [Figure 27E] FIG. 13 is a perspective view of a thirteenth embodiment of a TMM device of the present disclosure as a two-layer multiwell insert. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0053] Non-limiting definitions 1A-11F, 19A-21B, and 27A-27E, the terms "sample core region" and "sample core" may be used herein to describe a central region of the bottom wall 22 of the base 20a of any one of devices 10a-10g, 110a, 110d, 110e, 110f, and 110g, with the outer boundary of the "sample core region" or "sample core" physically marked by an inner ring of core posts 26.
[0054] The terms "wet zone region" and "wet zone" may be used herein to describe the area on bottom wall 22 of base 20a around or adjacent to the sample core and bounded by the inner ring of core struts 26 and the outer ring of peripheral struts 28 of any one of devices 10a-10g, 110a, and 110d-110g.
[0055] The terms "media tank" or "media reservoir" may be used herein to describe the volume provided in the area between the inner surface of the cylindrical peripheral wall 24, the circular inner surface 22 of the base 20a, and the inner mating wall 42 of the lid 40a.
[0056] TMM Devices Referring now to the drawings, and in particular to Figures 1A-7E, an embodiment of a tumor microenvironment mimicking ("TMM") device 10a and associated methodology is illustrated. TMM device 10a and any of the alternative TMM devices 10b-10h may be formed in whole or in part from one or more biocompatible metals, such as titanium and titanium alloys, stainless steel, Ni-Ti alloys (Nitinol®), and / or cobalt-chromium alloys. TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g may alternatively or additionally be formed in whole or in part from one or more ceramic biomaterials, such as alumina / aluminosilicates, bioglass and / or AW glass ceramics, hydroxyapatite, zirconia, tricalcium phosphate, carbon / carbon filter / pyrolytic carbon (LTI) / vitreous carbon, carbides, calcium phosphates, and / or graphite.
[0057] The TMM devices 10a-10h, 110a, and 110d-110g may be made of any of a variety of materials, including polydimethylsiloxane ("PDMS"), resin / phenol formaldehyde resin / melamine resin / polyepoxide, polyvinyl chloride ("PVC"), polyvinyl alcohol ("PVOH"), polyvinyl acetate ("PVAC"), polyvinylidene chloride ("PVDC"), polyvinyl butriol ("PVB"), polyethylene ("PE"), polypropylene ("PP"), polymethyl methacrylate ("PMMA"), polystyrene ("PS"), polytetrafluoroethylene ("PTFE"), polyurethane ("PU") and polyamide (nylon), polyethylene terephthalate ("PET"), polyethersulfone ("PES"), polyetherimide ("PEI"), medical grade silicone, TMC NAD-lactide, polylactic acid (PLA), cyclic olefin copolymers ("COC"), polycarbonate ("PC"), polyetheretherketone ("PEEK"), poly(lactic-co-glycolic acid) ("PLGA"), acrylonitrile-butadiene-styrene ("ABS") and other styrene copolymers (SAN, MBS, SBS, SIS), acetal-polyoxymethylene ("POM"), ethylene vinyl acetate copolymer ("EVA"), polyacrylonitrile-butadiene-styrene ("POM"), polyacrylonitrile-butadiene-styrene ("POM"), polyacrylonitrile-butadiene-styrene ("PAM ... Alternatively, or additionally, it may be formed in whole or in part from one or more polymers, such as polystyrene ("PAN"), celluloid acetate ("CA"), polybutylene terephthalate ("PBT"), polytetramethylene terephthalate ("PTMT"), polytetrafluoroethylene ("PTFE"), polychlorotrifluoroethylene ("PCTFE"), polyvinyl fluoride ("PVDF"), polyimide ("PI"), and / or trimethyl carbonate.
[0058] Any components of devices 10a-10h, 110a, and 110d-110g made from biocompatible metals may be machined or formed. Any components of devices 10a-10h, 110a, 110d, 110e, 110f, and 110g made from ceramic biomaterials may be machined or formed as well. Any components of devices 10a-10h, 110a, and 110d-110g made from polymers may be molded, for example, injection molded, or made from three-dimensional printing or additive manufacturing processes.
[0059] 1A shows that the TMM device 10a includes a base 20a. The base 20a includes a bottom wall 22 from which a peripheral wall 24 extends. In the illustrated embodiment, the bottom wall 22 is circular and the peripheral wall 24 is cylindrical. The bottom wall 22 in the illustrated embodiment includes an inner ring of core struts 26 and an outer ring of peripheral struts 28. The rings of struts 26 and 28 are circular in one embodiment. The struts 26 and 28 may each extend perpendicularly from the bottom wall 22 and may have inner and outer curved or radiused surfaces. The struts 26 in the illustrated embodiment are the same height but have a smaller diameter than the struts 28.
[0060] In the illustrated embodiment, the top of the peripheral wall 24 is provided with mounting holes 30 that allow for mounting of the lid 40a of the TMM device 10a in a selected desired orientation relative to the base 20a. The mounting holes 30 may be threaded to threadably receive the threaded bolts 32 shown in FIG. 1A. FIG. 1A also shows that the TMM device 10a includes a media tank sealer 34, which will be discussed in detail below. The threaded bolts 32 and media tank sealer 34 may be made from any of the materials discussed herein.
[0061] FIG. 1B shows that the TMM device 10a includes a lid 40a that is adjustably attached to the base 20a. FIG. 1B shows the underside of the lid 40a in more detail. The lid 40a is flipped 180 degrees from the position shown in FIG. 1B for attachment to the base 20a. In the illustrated embodiment, the lid 40a includes an inner mating wall 42 that is raised or offset from an outer sealing flange 44. Similar to the posts 26 and 28 of the base 20a, the inner mating wall 42 is provided with a ring of posts 48 extending from the mating wall. The posts 48 may each extend perpendicularly from the inner mating wall 42 and may have inner and outer curved or radiused surfaces. The height of the posts 48 may be the same as the height of the posts 28 of the base 20a.
[0062] In one embodiment, the height of the peripheral wall 24 of the base 20a, the amount that the mating wall 42 is raised or offset from the outer sealing flange 44, and the height of the posts 28 and 48 are selected so that when the lid 40a is attached to the base 20a, (i) the tops of the posts 28 slidably mate with the mating surface of the mating wall 42, and (ii) the tops of the posts 48 slidably mate with the mating surface of the bottom wall 22 of the base 20a. Also, and as shown below, the rings of posts 28 and 48 may have a radius or diameter sized such that the outer curved or radiused surface of the posts 48 slidably mate with the inner curved or radiused surface of the posts 28.
[0063] In the illustrated embodiment, the zone dividers 46a and 46b extend upwardly from the mating wall 42. The zone dividers 46a and 46b may be generally rectangular in shape lengthwise and have the same height as the post 48. The zone dividers 46a and 46b may also be sized to extend inwardly to slidably mate with (or closely approximate) an exterior curved or radiused surface of the post 26 when the lid 40a is attached to the base 20a, as shown below.
[0064] The environmental dividers 50a and 50b extend from or are attached to the sides of the mating wall 42. The environmental dividers 50a and 50b are spaced from the outer edges of the area dividers 46a and 46b, respectively, by a gap G. The gap G is sized and positioned to receive the posts 28 of the base 20a when the user twists the lid 40a to a desired position relative to the base. The environmental dividers 50a and 50b also provide a barrier between the mating wall 42 of the lid 40a and the peripheral wall 24 of the base 20a when the lid 40a is attached to the base 20a. The environmental dividers 50a and 50b also regulate the intake of medium and ambient air through small cuts in the mating wall 42.
[0065] In the illustrated embodiment, the mating wall 42 forms or defines medium input openings 52o and 52c for injecting medium (as described in detail below) into the cavity formed between the mating wall 42 and the bottom wall 22 when the lid 40a is attached to the base 20a.
[0066] In the illustrated embodiment, the outer sealing flange 44 forms or defines mounting holes 54 and input holes 56. The mounting holes 54 are spaced to align with the threaded mounting holes 30 formed or defined in the peripheral wall 24 of the base 20a. After a user aligns the mounting holes 54 with the desired set of mounting holes 30, as shown in FIG. 2, the user secures the lid 40a to the base 20a by inserting threaded bolts 32 into the mounting holes 54 and tightly threading the bolts into the threaded mounting holes 30.
[0067] The input holes 56 are spaced closer together than the mounting holes 54. When the lid 40a is attached to the base 20a, the input holes 56 are spaced to provide selective access to the space between the inner surface of the peripheral wall 24 and the outer surface of the mating wall 42. The purpose of selective access to that space is to allow medium and oxygen to enter the TMM device 10a, as discussed in more detail below. As shown in FIG. 2, when selective access to that space is not required, the input holes 56 are blocked via the medium tank sealer 34.
[0068] FIG. 1C shows that the TMM device 10a further includes a core sealer 60a (as shown in FIG. 2) that the user places on the top side of the lid 40a after depositing any desired medium into the cavity formed between the mating wall 42 and the bottom wall 22 when the lid 40a is attached to the base 20a. FIG. 1C shows the underside of the core sealer 60a in more detail. The core sealer 60a is flipped 180 degrees from the position shown in FIG. 1C for placement on the mating wall 42 of the lid 40a. In the illustrated embodiment, the underside of the core sealer 60a forms or defines a plug 62 that plugs the deposit openings 52o and 52c of the mating wall 42 of the lid 40a. In this manner, the cavity formed between the mating wall 42 and the bottom wall 22 when the lid 40a is attached to the base 20a is sealed against the surrounding environment when the core sealer 60a is placed on the mating wall 42 of the lid 40a.
[0069] 1D illustrates a second embodiment of the lid 40a in which the environmental dividers 50a and 50b extend further from the mating wall 42 such that the environmental dividers 50a and 50b engage with notches 31 in the peripheral wall 24 of the base 20a in a selected desired orientation. It should be understood that the second embodiment of the lid 40a does not include the mounting holes 54 or the threaded bolts 34. It should also be understood that in the absence of the mounting holes 54 or the threaded bolts 34, the second embodiment of the lid 40a may be fastened to the second embodiment of the base 20a using an alternative locking mechanism such as a snap fit or a mounting boss.
[0070] 1E shows a second embodiment of base 20a in which peripheral wall 24 includes a notch 31 that allows lid 40a of TMM device 10a to engage base 20a in a selected desired orientation. The thickness of peripheral wall 24 is such that notch 31 does not extend therethrough.
[0071] The following text describes the device 10a using the screw embodiment as shown in Figures 1A and 1B, but the engagement between the notch 31 and the extended environmental dividers 50a and 50b can be applied as an alternative according to Figures 1D and 1E. Such engagement may be provided in combination with any and all of the text related to Figures 3-7E.
[0072] FIG. 3 shows the components of the TMM device 10a simply described in an exploded view to provide additional spatial detail. Starting from the top, the TMM device 10a includes a core sealer 60a having plugs 62 that plug input openings 52o and 52c in the mating wall 42. Threaded bolts 32 extend through mounting holes 54 formed in the outer seal flange 44 and thread into threaded mounting holes 30 formed or defined in the peripheral wall 24. The tank sealer 34 selectively plugs input holes 56 formed in the outer seal flange 44 when required by the user. The peripheral wall 24 extends around the cylindrical side of the mating wall 42. Environmental dividers 50a and 50b provide a barrier between the side of the mating wall 42 and the peripheral wall 24. Area dividers 46a and 46b and a ring of support posts 48 are formed with or attached to the underside of the mating wall 42. An inner ring of core struts 26 and an outer ring of perimeter struts 28 are formed with or attached to the top side of bottom wall 22. The ring of struts 48 slidably fits within the ring of perimeter struts 28.
[0073] FIG. 4 is a cross-sectional view of the TMM device 10a highlighting the specific interactions between the base 20a, the lid 40a, and the core sealer 60a. In particular, FIG. 4 illustrates that the medium tank sealer 34 selectively fills or blocks the input holes 56 to close and seal the space S between the peripheral wall 24 and the sidewall of the mating wall 42. Also, one of the plugs 62 of the core sealer 60a is shown filling or blocking one of the medium input openings 52c of the mating wall 42. Additionally, the post 48 of the mating wall 42 of the lid 40a is shown slidably engaging the peripheral post 28 of the bottom wall 22 of the base 20a. Additionally, the mating wall 42 and the bottom wall 22 are illustrated forming a cavity C in which the medium is grown, as will be discussed in more detail below.
[0074] FIG. 5 is a different cross-sectional view of the TMM device 10a highlighting additional interactions between the base 20a, the lid 40a, and the core sealer 60a. In particular, FIG. 5 illustrates the threaded bolt 32 extending through the mounting hole 54 formed in the outer sealing flange 44 of the lid 40a and threading into the threaded mounting hole 30 formed in the peripheral wall 24 of the base 20a. Again, one of the plugs 62 of the core sealer 60a is shown filling or blocking one of the medium input openings 52c of the mating wall 42. Additionally, the environmental dividers 50a and 50b are shown blocking the space S of FIG. 4 between the peripheral wall 24 and the side wall of the mating wall 42. Additionally, the gap G formed between the zone dividers 46a and 46b and the environmental dividers 50a and 50b, respectively, is shown slidably filled by the posts 28 of the bottom wall 22 of the base 20a.
[0075] Figure 6 is yet another cross-sectional view of the TMM device 10a highlighting further additional interactions between the base 20a, the lid 40a, and the core sealer 60a. In particular, Figure 6 illustrates that all three plugs 62 of the core sealer 60a fill or block all three input openings 52o and 52c of the mating wall 42. Additionally, the posts 48 of the mating wall 42 of the lid 40a are shown to slidably engage the perimeter posts 28 of the bottom wall 22 of the base 20a.
[0076] 7A-7E illustrate five different possible attachment or engagement configurations between the lid 40a and the base 20a. Although five configurations are illustrated, more or less than five configurations may be provided. These configurations are defined by 180 degree pairs of threaded mounting holes 30. The user rotates the lid 40a so that the mounting holes 54 (not shown in FIGS. 7A-7E) in the outer sealing flange 44 are aligned with the desired pair of threaded mounting holes 30, and then bolts the lid 40a to the base 20a in place using threaded bolts 32. The selection of one of the pairs of threaded mounting holes 30 is based on how open the user wants the cell culture to oxygen and / or medium. Medium and / or oxygen may be provided, for example, in the space S illustrated in FIGS. 4 and 6, which may be opened to the surrounding atmosphere by removing the medium tank sealer 34 from the input hole 56 formed in the outer sealing flange 44 of the lid 40a.
[0077] The amount that the TMM device 10a is open is determined by the relative slidable position between the rings of posts 48 of the lid 40a and the rings of posts 28 of the base 20a. In Figures 7A-7E, the core sealer 60a has been completely removed and the mating wall 42 and outer seal flange 44 of the lid 40a have been removed to show the interaction of the posts 48 with the posts 28 provided by or attached to the bottom wall 22 of the base 20a. The area dividers 46a and 46b and the environmental dividers 50a and 50b of the lid 40a are also shown, and are aligned with the mounting holes 54 of the lid 40a that mate with the threaded mounting holes 30 of the base 20a, thus indicating user selection.
[0078] In FIG. 7A, the user has selected to mount the lid 40a in the counterclockwise furthest pair of screw mounting holes 30, which corresponds to the posts 48 and 28 being perfectly aligned to provide the most medium and / or oxygen in an "environmentally open" setting. In FIG. 7B, the user has selected to mount the lid 40a in the second counterclockwise furthest pair of screw mounting holes 30, which corresponds to the posts 48 and 28 being slightly offset to provide the second most "environmentally open" setting. In FIG. 7C, the user has selected to mount the lid 40a in the middle pair of screw mounting holes 30, which corresponds to the posts 48 and 28 being offset approximately halfway to provide a middle "environmentally open" setting. In Figure 7D, the user has selected to mount the lid 40a to the second, most clockwise, pair of screw mounting holes 30, which corresponds to posts 48 and 28 being almost offset, providing the second, most "environmentally closed" configuration. In Figure 7E, the user has selected to mount the lid 40a to the second, most clockwise, pair of screw mounting holes 30, which corresponds to posts 48 and 28 being completely offset, providing the most "environmentally closed" configuration.
[0079] 8A-8F, an alternative TMM device 10b is shown having substitutions between the base 20b, lid 40b, and core sealer 60b, which may be made of any of the materials described above. Alternative TMM device 10b includes many of the same components as TMM device 10a, are numbered the same, and includes all of the structures, features, and substitutions described above for those components. The primary difference with TMM device 10b is how the "environmental open" setting is performed and how medium and / or oxygen is allowed to reach the injected medium.
[0080] The lid 40b of the TMM device 10b does not have an outer seal flange 44, is not bolted to the base 20b, and is generally flat, as is the core sealer 60b. Thus, the peripheral wall 24 of the base 20b does not have threaded mounting holes 30. The bottom wall 22 of the base includes an inner ring of core posts 26 and an outer ring of peripheral posts 28, as before. The lid 40b provides zone dividers 46a and 46b and a ring of posts 48, as before. Environmental dividers 50a and 50b are not provided with the lid 40b.
[0081] Base 20b includes guides 36a-36c that are formed with or attached to bottom wall 22 and extend upwardly from bottom wall 22. Guides 36a-36c are spaced apart a distance approximately equal to the diameter of mating wall 42 of lid 40b. Guides 36a-36c therefore center lid 40b when placed on base 20b such that posts 48 slidably engage peripheral posts 28, similar to TMM device 10a. Varying engagement of posts 48 and posts 28 (from fully aligned to fully offset) varies the medium and / or oxygen "environmental openness" for TMM device 10b in the same manner as described for TMM device 10a.
[0082] Guide 36a is formed with or attached to protrusions 38. Mating wall 42 is formed with a plurality of identical recesses 58, e.g., three to five recesses, corresponding to the "environmentally open" setting in a manner similar to threaded holes 30 of TMM device 10b. The recesses 58 snap-fit into the protrusions 38 of guide 36a to temporarily hold lid 40b in a desired position ("environmentally open" setting) relative to base 20b until a user wishes to change the setting and rotate lid 40b. If desired, guides 36b and / or 36c may also include protrusions 38 to mate with their own set of recesses 58 formed in mating wall 42. Unlike TMM device 10a, medium and / or oxygen can freely reach posts 28 and 48. In TMM device 10b, there is no secondary space S (FIGS. 4 and 6) that can be sealed and unsealed via medium tank sealer 34.
[0083] FIG. 8D shows the assembled TMM device 10b. The core sealer 60b is substantially the same as the core sealer 60a and includes plugs 62 that plug the input openings 52o and 52c in the mating wall 42 of the lid 40a. The core sealer 60b can be formed with a smaller diameter than the mating wall 42 (FIG. 8C) so as not to interfere with the projection 38 of the guide 36a. Or, as shown in FIG. 8D (and FIG. 8F), the core sealer 60b can be formed with the same diameter as the mating wall 42 and can include its own recess 68, for example, of the same shape as the recess 58, which in turn snap-fits over the projection 38 of the guide 36a to additionally temporarily hold the lid 40b in place. In a further alternative embodiment, the recess 58 in the mating wall 42 is not provided and only the recess 68 in the core sealer 60b is provided. Rotating the core sealer 60b also rotates the lid 40a, which is in mechanical communication with the plug 62 of the core sealer 60b and the input openings 52o and 52c in the mating wall 42.
[0084] FIG. 8E is a cross-sectional view of the TMM device 10b highlighting the specific interactions between the base 20b, the lid 40b, and the core sealer 60b. In particular, FIG. 8E illustrates that all three plugs 62 of the core sealer 60b fill or block all three input openings 52o and 52c of the mating wall 42. Additionally, the posts 48 of the mating wall 42 of the lid 40b are shown to slidably engage the peripheral posts 28 of the bottom wall 22 of the base 20b. FIG. 8E also illustrates a cavity C that exists between the mating wall 42 and the bottom wall 22 in which the culture medium is grown, as will be discussed in more detail below.
[0085] FIG. 8F is a different cross-sectional view of the TMM device 10b highlighting additional interactions between the base 20b, the lid 40b, and the core sealer 60b. In particular, FIG. 8F shows one of the recesses 58 that snap-fits and interacts with the protrusion 38 of the guide 36a to temporarily hold the lid 40b in place. FIG. 8F also illustrates that one of the plugs 62 of the core sealer 60b fills or blocks the input opening 52c of the mating wall 42. Additionally, the post 48 of the mating wall 42 of the lid 40b is shown to slidably engage the peripheral post 28 of the bottom wall 22 of the base 20b.
[0086] 9A-9F, another alternative TMM device 10c is shown having an alteration between the base 20c, lid 40c, and core sealer 60c, which may be made of any of the materials described above. The alternative TMM device 10c includes many of the same components as TMM device 10b, numbered the same, and includes all of the structures, features, and alterations described above for those components. Again, guides 36a-36c center the lid 40c when placed on the base 20c, such that the posts 48 slidably engage the peripheral posts 28, similar to TMM device 10b. The varying engagement of posts 48 and 28 (from fully aligned to fully offset) changes the "environmental openness" of medium and / or oxygen for TMM device 10c in the same manner as described for TMM device 10a. Also, similar to TMM device 10b, medium and / or oxygen can freely reach the posts 28 and 48. In TMM device 10c, there is no secondary space S (FIGS. 4 and 6) that can be sealed and unsealed via media tank sealer 34. The primary differences between TMM device 10c and TMM device 10b are how lid 40c is held in place and that zone dividers 46a and 46b are not provided.
[0087] Figure 9A illustrates that base 20c is the same as base 20b, except that guide 36a does not include protrusion 38. Thus, lid 40c in Figure 9B does not include recess 58, and core sealer 60c in Figures 9C and 9D does not include recess 68. Instead, the diameter of mating wall 42 can be sized to press-fit into guides 36a-36c of base 20c such that lid 40c is temporarily held in place when pressed between guides 36a-36c until a user decides to rotate lid 40c relative to base 20c.
[0088] Zone dividers 46a and 46b in TMM devices 10a and 10b allow different media to be injected and present simultaneously in cavity C of the TMM device. The lack of zone dividers 46a and 46b in TMM device 10c means that only a single cell type can be injected into cavity C of the TMM device at a given time. Thus, only two medium entry openings 52o and 52c need to be formed in mating wall 42, and only two corresponding plugs 62 need to be provided by core sealer 60b.
[0089] 9E and 9F are cross-sectional views of the TMM device 10c highlighting the specific interactions between the base 20c, the lid 40c, and the core sealer 60c. In particular, FIG. 9E illustrates that the central plug 62 of the core sealer 60c fills or blocks the input opening 52c of the mating wall 42. FIG. 9F illustrates that the plug 62 of the core sealer 60c fills or blocks both input openings 52o and 52c of the mating wall 42. Additionally, the posts 48 of the mating wall 42 of the lid 40c are shown to slidably engage the peripheral posts 28 of the bottom wall 22 of the base 20c. The lid 40c and the core sealer 60c are also shown and are fitted against the guide 36a (as well as against the guides 36b and 36c). FIG. 9F further illustrates a cavity C that exists between the mating wall 42 and the bottom wall 22 that contains the medium and oxygen, as will be described in more detail below.
[0090] 10A-10F, a further alternative TMM device 10d is shown having an alteration between the base 20d, the lid 40d, and the core sealer 60d, which may be made of any of the materials described above. As best shown in FIGS. 10A-10C, the further alternative TMM device 10d is the same device as TMM device 10b (FIGS. 8A-8F), except that the peripheral wall 24 of the base 20d is not provided. All other common components are numbered the same and operate in the same manner, including all alterations. Again, guides 36a-36c center the lid 40d when placed on the base 20d, such that the posts 48 slidably engage the peripheral posts 28, similar to TMM device 10b. The varying engagement of the posts 48 and 28 (from fully aligned to fully offset) changes the "environmental openness" of medium and / or oxygen for TMM device 10d in the same manner as described for TMM device 10a. Also, similar to TMM devices 10b and 10c, medium and / or oxygen can freely reach posts 28 and 48, especially now with surrounding wall 24 removed.
[0091] Similar to TMM device 10b, recess 58 of lid 40d snaps into protrusion 38 of guide 36a of TMM device 10d to temporarily hold lid 40d in a desired position relative to base 20d ("environmentally open" setting) until a user desires to change settings and rotate lid 40d. Similarly, as shown in Figures 10C and 10D, recess 68 of core sealer 60d snaps into protrusion 38 of guide 36a of TMM device 10d to temporarily hold lid 40d in a desired position relative to base 20d ("environmentally open" setting).
[0092] 10E and 10F are cross-sectional views of the TMM device 10d highlighting certain interactions between the base 20d, the lid 40d, and the core sealer 60d. In particular, FIG. 10E (and FIG. 10F) illustrates that the central plug 62 of the core sealer 60d fills or blocks the input opening 52c of the mating wall 42. In particular, FIG. 10E also illustrates one of the recesses 58 and 68 that snap-fit and interact with the protrusion 38 of the guide 36a to temporarily hold the lid 40d in place. Additionally, the posts 48 of the mating wall 42 of the lid 40d are shown to slidably engage the peripheral posts 28 of the bottom wall 22 of the base 20d. FIG. 10E further illustrates a cavity C that exists between the mating wall 42 and the bottom wall 22 in which the culture medium is grown, as will be discussed in more detail below. FIG. 10F also shows zone dividers 46a and 46b in cross section, which allow different media to be cultured simultaneously on different sides of the divider.
[0093] 11A-11F, yet another alternative TMM device 10e is shown having an alteration between the base 20e, the lid 40e, and the core sealer 60e, which may be made of any of the materials described above. As best shown in FIGS. 11A-11C, yet another alternative TMM device 10e is the same device as TMM device 10c (FIGS. 9A-9F), except that the peripheral wall 24 of the base 20e is not provided. All other common components are numbered the same and operate in the same manner, including all alterations. Again, guides 36a-36c center the lid 40d when placed on the base 20d, such that the posts 48 slidably engage the peripheral posts 28, similar to TMM device 10b. The varying engagement of the posts 48 and 28 (from fully aligned to fully offset) changes the "environmental openness" of medium and / or oxygen for TMM device 10d in the same manner as described for TMM device 10a. Also, similar to TMM devices 10b-10d, medium and / or oxygen can freely reach posts 28 and 48, especially now with surrounding wall 24 removed.
[0094] FIG 11A shows that, like base 20c, base 20e includes guides 36a-36c but does not include protrusions 38. Thus, lid 40e of FIG 11B does not include recess 58, and core sealer 60c of FIG 11C and FIG 11D does not include recess 68. Instead, the diameter of mating wall 42 can be sized to press-fit into guides 36a-36c of base 20e such that lid 40e is temporarily held in place when pressed between guides 36a-36c until a user decides to rotate lid 40e relative to base 20c.
[0095] 11E and 11F are cross-sectional views of the TMM device 10e highlighting the specific interactions between the base 20e, the lid 40e, and the core sealer 60e. In particular, FIG. 11E illustrates that the plug 62 of the core sealer 60e fills or blocks both input openings 52o and 52c of the mating wall 42. Additionally, the posts 48 of the mating wall 42 of the lid 40e are shown to slidably engage the peripheral posts 28 of the bottom wall 22 of the base 20e. The lid 40e and the core sealer 60e are also shown and are fitted to the guide 36a (as well as to the guides 36b and 36c). FIG. 11F illustrates that the central plug 62 of the core sealer 60e fills or blocks the input opening 52c of the mating wall 42. FIG. 11F further illustrates the cavity C that exists between the mating wall 42 and the bottom wall 22 in which the medium is grown, as will be discussed in more detail below.
[0096] 11G-11J, an alternative TMM device 110e is shown that may be made of any of the materials discussed herein. The alternative TMM device 110e includes many of the same components as TMM device 10e, are numbered the same, and includes all of the structures, features, and alternatives described above for those components. Specifically, TMM device 110e includes inner ring struts 26, outer ring struts 28, and guide struts 36a-36c as illustrated in device 10e. For simplicity, inner ring struts 26, outer ring struts 28, and guide struts 36a-36c are collectively referred to herein as the "ring configuration."
[0097] Although sharing the ring construct with TMM device 10e and other devices, TMM device 110e differs from TMM device 10e and other devices because TMM device 110e provides a modified structure and function. TMM device 110e places the ring assembly on slide 25, which facilitates easy observation under a microscope with a slide holder. TMM device 110e can also allow the user to observe multiple samples exposed to the same tissue culture medium (growth factors, drugs, chemoattractants) if separation wall 31 is removed as shown in FIG. 11J. Furthermore, device 110e includes two ring constructs, slide 25, housing 27, and lid 35. Slide 25 provides a base for both housing 27 and ring constructs. Housing includes a perimeter wall 29 and a partition wall 31 that separates the two ring constructs. Perimeter wall 29 includes a lip 33 that engages with lid 35. Lid 35 is used to cover the samples and keep them sterile.
[0098] FIG 11H shows a cross-sectional view of TMM device 110e including two ring arrangements, slide 25, and housing 27. FIG 11I shows an assembled cross-sectional view of TMM device 110e including two ring arrangements, slide 25, housing 27, lid 35, core sealer 60d, and lid 40d. FIG 11J shows an alternative embodiment of TMM device 110e, where TMM device 110e is provided without partition wall 31 located within housing 27.
[0099] 11K and 11L, an alternative TMM device 110d is shown. FIG. 11K shows the device 110d in its entirety, and FIG. 11L is a cross-sectional view of one of the multiple ring arrangements 37 located within its own well 41. The alternative TMM device 110d includes many of the same components as TMM device 10d, which are numbered the same, and includes all of the structures, features, and alternatives described above for those components. Specifically, TMM device 110d includes multiple ring arrangements 37 located on plate 39. Each ring arrangement 37 is located within its own well 41 (FIG. 11L).
[0100] 11M-11P, an alternative TMM device 110a is shown and may be made of any of the materials discussed herein. The alternative TMM device 110a includes many of the same components as TMM device 10a, are numbered the same, and includes all of the structures, features, and alternatives described above for those components. The TMM device 110a allows for full adjustment of external factors and compression. FIG. 11M shows that the TMM device 110a includes a slide 45, a slide base 47, a slide lid 49, and a slide core sealer 51. The slide 45 includes ring configurations, environmental sealers 50a and 50b, and zone dividers 46a and 46b. The slide lid 49 includes medium input openings 52o and 52c, mounting holes 54, and input holes 56. The slide core sealer 51 includes a plug 62 that blocks the input opening 52 of the slide lid 49. The threaded bolt 32 extends through the mounting hole 54 and threads into the threaded mounting hole 30 formed or defined in the sliding base 47. The tank sealer 34 selectively blocks the input hole 56 in the sliding lid 49 when desired by a user.
[0101] 12A and 12B, there is shown yet another alternative TMM device 10f that can be made of any of the materials discussed herein.
[0102] 19A and 19B, an alternative TMM device 10d is shown and may be made of any of the materials discussed herein. Alternative TMM device 10g includes many of the same components as TMM device 10d, are numbered the same, and includes all of the structures, features, and alternatives described above for those components. In contrast to 10d, 10g does not include guides 36a-36c, but does have guides 59a and 59b that allow for a snap fit of the lid of 40f through cavity 58b, which corresponds to an "ambient open" setting in a manner similar to threaded hole 30 of TMM device 10b. Additionally, zone dividers 46a and 46b are located in base 22 and extend outwardly from core posts (26) to outer posts (28), which provide a physical separation of the infiltration zones, thereby creating two or more distinct infiltration zones.
[0103] 20A-20C, an alternative TMM device 110e is shown and may be made of any of the materials discussed herein. Alternative TMM device 110f includes many of the same components as TMM device 110d, are numbered the same, and includes all of the structures, features, and alternatives described above for those components. In contrast to 110d, 110f does not include a bottom slide 25, as all features are attached to the perimeter wall 33, thus allowing for the introduction of any of the see-through materials discussed herein to allow for high resolution microscopy. Additionally, posts 26 and 28 are attached to the top wall 23, forming two concentric semicircles, and located in individual wells 66. Additionally, input guides for ECM mimic 52b and core loader 52a are located in individual wells 65 and are connected to either the infiltration zone or the core sample, respectively. Each well set of input guides is sealed using lid 60f by forming a tight seal between the well 65 and plug 62. Lid 35 is used to cover the samples and keep them sterile.
[0104] 21A and 21B, an alternative TMM device 110d is shown that is a multi-well embodiment of 110f and can be made of any of the materials discussed herein. Alternative TMM device 110g includes many of the same components as TMM device 110f, are numbered the same, and includes all of the structures, features, and alternatives described above for those components.
[0105] Figures 27A-27E show TMM device 10H, which may be made of any of the materials discussed herein, as a two-layer embodiment of TMM devices 10e and 10f. TMM device 10H includes a base (69) as its top layer (Figures 27A and 27B), which has cylindrical struts that form a ring and extend to mate with bottom base (70) to form the invasion zone of TMM device 10H. There is also an ECM-mimicking input opening (52d) located in the center of base 69, which allows for the introduction of any ECM-mimicking and any cell type into the invasion zone of TMM device 10H after setup. Additionally, top layer (69) acts as a sealer for the invasion zone of TMM device 10H, but allows for the uptake of both nutrients and oxygen through ECM-mimicking input opening (52d). Variable uptake can be achieved by variation in the diameter of this opening and mimicking intravascular insertion by covering the intake opening with a porous polyester membrane and introducing an endothelial cell monolayer on top of the membrane. Additionally, bottom base (70) has cylindrical posts (72) that form a ring and define a core region of the TMM device 10H, similar to the core posts 26 described above. Bottom base (70) also has small extrusions (73) around its periphery to allow nutrients and oxygen to diffuse into the core region.
[0106] Devices 10a-10h, 110a, 110d, 110e, 110f, and 110g may be sterilized by any method known to one of skill in the art. Additionally, at least TMM devices 10a-10g may be used with petri dishes and / or multi-well formats, including but not limited to 2-, 4-, 6-, 12-, 24-, 46-, and / or 96-well plates. Any one or more or all of TMM devices 10a-10g may be scaled to size as needed to be inserted into any petri dish, multi-well plate format (e.g., as shown in Figures 11M-11P and 11G-11I), and / or microscope slide holder format (e.g., as shown in Figures 11M-11P and 11G-11I). Additionally or alternatively, the features of the TMM device can be directly incorporated into any petri dish, multi-well plate format (e.g., as shown in Figures 11M-11P and 11G-11I), and / or microscope slide holder format (e.g., as shown in Figures 11M-11P). A suitable lid or cover is used to set the desired intake of medium and / or oxygen.
[0107] Additionally, features of any of the TMM devices 10a-10g can be produced directly in the wells of a multiwell plate (e.g., as shown in Figures 11M-11P and 11G-11I) or in a microscope slide format (e.g., as shown in Figures 11M-11P). Alternatively, the base posts (26 and 28) can be moved to a base (23) that mates with a section of the perimeter wall to produce a multiwell format (e.g., as shown in Figures 21A and 21B) or a microscope slide format (e.g., as shown in Figure 20A), which does not have a bottom to allow for post-fabrication introduction of a transparent base that can be fabricated by any of the materials discussed herein. Finally, the main features can also be established in a 96-well plate format that allows for high throughput screening through the use of a two-layer device, as shown in Figures 27A-27E.
[0108] TMM method Any of the TMM devices 10a-10h, 110a, and 110d-110g can be used to mimic the tumor microenvironment and investigate cell invasion, cell migration, and / or cell response to various environmental factors or other cells. In addition, any of the TMM devices 10a-10h, 110a, and 110d-110g may be used to isolate increasingly aggressive cancer cell subpopulations. Cells of interest can be deposited in the sample core region through the opening 52c of any of the TMM devices 10a-10g, 110a, 110d, 110e, 110f, and 110g, as shown in Figures 13A-13E, which illustrates one embodiment of the disclosed method for preparing a microtumor assay protocol. In Figure 13A, cells of interest are subjected to centrifugation and the supernatant is removed. In Figure 13B, the pellet of cells is resuspended, for example, in a selected hydrogel polymer to achieve a final concentration of between 5,000-150,000 cells / μl, or more preferably, between about 40,000-80,000 cells / μl. In Figure 13C, the resuspended cells are delivered or added to the sample core of any of devices 10a-10h, 110a, 110d, 110e, 110f, and 110g.
[0109] In FIG. 13D, a round glass cover slip or suitable lid (for any of TMM devices 10a-10g, 110a, 110d, 110e, 110f, and 110g) may be placed to cover the delivered cells. For devices 10a-10g, lids 40a-40f are placed on their respective bases 20a-20e, and the user rotates the lids 40a-40f to the desired "environmental openness" setting of medium and / or oxygen for the respective bases 20a-20e in the manner shown above. A core sealer 60a-60e may then be placed on each lid 40a-40e to seal their openings 52.
[0110] In FIG. 13E, the selected extracellular matrix ("ECM") mimic is introduced into the invasion zone region of devices 10a-10h, 110a, 110d, 110e, 110f, and 110g through the side opening (FIG. 13E). In FIG. 13F, devices 10a-10h, 110a, 110d, 110e, 110f, and 110g are placed again in the incubator for polymerization, if necessary, for example, when using some hydrogels as the selected ECM. Cell culture medium is added to the medium reservoir of devices 10a-10h, 110a, 110d, 110e, 110f, and 110g. In FIG. 13G, devices 10a-10h, 110a, 110d, 110e, 110f, and 110g are ready for use and can be observed in an incubator for further analysis of cell 3D migration and / or invasion.
[0111] Because cells within the sample core of devices 10a-10h, 110a, 110d, 110e, 110f, and 110g consume nutrients and oxygen, the immediate microenvironment within the sample core can mimic the necrotic core or hypoxic region of a tumor. Generally, the invasion zone surrounding the sample core presents fewer environmental challenges compared to the sample core region, due in part to a larger surface area. Thus, the invasion zone region can provide a more desirable microenvironment for cells within the sample core. Environmental factors may include, but are not limited to, oxygen, pressure, cellular nutrients, other cells, chemoattractants, and / or growth factors. Cells within the sample core may migrate or invade the invasion zone region. Additionally or alternatively, one or more of the environmental factors within the invasion zone may be less desirable, rather than more desirable, compared to the sample core.
[0112] Figures 16, 22, 23, 17, and 18 show that the microenvironments within any of the TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g have the ability to replicate in vivo tumor phenotypes and microenvironments in vitro, as they are characterized by the establishment of oxygen, pH, and nutrient gradients, respectively, that induce the generation of a necrotic core within the 3D environment.
[0113] Furthermore, the exact replication of the in vivo tumor microenvironment described above allows for the isolation of cancer cell subpopulations that exhibit higher metastatic potential. Figure 14 shows an in vitro comparison of metastatic potential within the TMM device 10a for parental MDA-MB-231 and MDA TMM2 cell lines, where MDA-MB-231 cells were introduced into the 10a TMM device core, passed through and exited the invasion zone of the device, and then isolated from the device periphery, and the process was repeated. Figure 14 shows that MDA TMM2 cells have higher in vitro metastatic potential than their parental cell lines, as they are able to pass through and exit the invasion zone of the TMM device significantly faster. Figures 24A and 24B also show that MDA TMM2 cells exhibit much more aggressive characteristics than the parental lines when used in xenograft experiments that showed faster tumor establishment, formation of larger primary tumors, and higher in vivo metastatic potential. Additionally, Figures 26A-C show that MDA TMM2 cells have elevated expression of proteins shown to promote tumor aggressiveness and progression, such as c-Myc oncoprotein and phosphorylated FAK (pFAK), as well as decreased expression of the tumor suppressor p53, which can prevent cancer cells from acquiring further mutations by inducing cell death, the downregulation of which is associated with worse prognosis in cancer patients.
[0114] Any of the TMM devices 10a-10h, 110a, and 110d-110g can be used for the isolation of cancer cell subpopulations from existing and already characterized cancer cell lines. This is a unique feature of the disclosed devices and methods, in that none of the in vitro assays used today have been demonstrated to allow for the isolation of heterogeneous subpopulations of cancer cells that exhibit increased aggressiveness that has been validated in vivo. Also, currently, most isolation of metastatic subpopulations or variants is performed in animal models by introducing cancer cells into animals and isolating metastatic lesions, which is a very time-consuming, laborious, and expensive process. Thus, the disclosed devices and methods can be used as an alternative method to animal models for the isolation of more aggressive cell subpopulations. Isolation of such subpopulations by any of the TMM devices can allow for direct and accurate determination of gene expression changes, epigenetic modifications, and metabolic changes involved in increased aggressiveness. Such studies are complicated when performed in vivo because the establishment of metastatic lesions at distant organs can significantly alter the expression profile of these cells due to dramatically different conditions at these sites compared to the original tumor location. This includes different growth factors, interacting cell types, and biomechanical differences such as tissue stiffness and mechanical stimuli. These gene expression changes that are a result of cancer cell growth at distant sites can mask gene expression, epigenetic, and metabolic changes that lead to increased aggressiveness, thus complicating the identification of gene expression changes. However, these limitations can be eliminated when cancer cell subpopulations are isolated using any of the TMM devices, as they only expose the cells of interest to environmental stressors and not variable mechanical stimuli or different tissue-specific signaling molecules.
[0115] Therefore, using the disclosed devices to compare isolated cancer cell subpopulations with their parental cell lines and with each other is of paramount importance since it can be used to understand and map genomic and transcriptional genetic changes in cancer cells, which can not only enhance understanding of tumor cell progression but also reveal diagnostic and prognostic markers that can enable early diagnosis and facilitate efficient treatment. In addition, cell subpopulations derived using the disclosed devices can be used for high-throughput studies for characterization of anti-metastatic drugs. Also, since any of the TMM devices 10a-10h, 110a, and 110d-110g can reproduce the in vivo tumor microenvironment and distinguish between metastatic and non-metastatic cells, they can be used to accurately evaluate novel anti-cancer drugs in a relevant environment and can be used as a rapid and accurate diagnostic tool and as a tool for testing different anti-cancer drugs for personalized treatment.
[0116] Additionally, any of the TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g may be used to co-culture at least one type of cell to investigate the effect that cellular interactions and / or additional cells may or may not have on tumor cell migration or invasion from the sample core to the invasion zone. In one embodiment, fibroblast cells may be added to the invasion zone. In another embodiment, endothelial or epithelial cells may be added to the periphery of the invasion zone to study tumor cell intravasation. Furthermore, in additional embodiments, two or more ECM materials and / or additional cell types may be added to different regions of the invasion zone.
[0117] The invasion zone may also contain any material that can resemble or mimic the extracellular matrix ("ECM"). The ECM mimic may be deposited in the entire area of the invasion zone or in a separate area within the invasion zone of any of the TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g. The ECM mimic may be introduced into the TMM device during initial setup of the device, as shown in FIG. 13E, or the ECM mimic may be deposited through one of the openings 52. In one embodiment, Matrigel® matrix may be added to the invasion zone of any of the TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g. In another embodiment, collagen may be added to the invasion zone of any of the TMM devices 10a-10g. The ECM mimic may include any biocompatible hydrogel or material in any acceptable concentration known to one of skill in the art.
[0118] Solution or medium can be added to the medium reservoir or tank of any of the TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g via input hole 56. Additionally or alternatively, any of the TMM devices 10a-10g, 110a, 110d, 110e, 110f, and 110g can be inserted into any petri dish, multi-well plate format (e.g., as shown in Figures 11M-11P, 11G-11I, and 21A-21B), and / or microscope slide holder format (e.g., as shown in Figures 11M-11P, and 20A-20C) and can be submerged in medium that is added to the well, dish, or holder itself. Any solution or medium known to one of skill in the art may be used. Various amounts of medium and / or solution known to one of skill in the art may be added to the medium reservoir or tank. The solution or medium can be replaced at any time by removing the solution or medium through input hole 56 and then adding replacement medium or new medium through input hole 56 .
[0119] In one embodiment, growth factors can be added to the medium located in the medium tank through input holes 56 of any of the TMM devices 10a-10g, 110a, 110d, 110e, 110f, and 110g. The concentration of growth factors in the medium can be any concentration known to one of skill in the art.
[0120] In one embodiment, zone dividers 46a and 46b extend outwardly from mating wall 42 to provide a physical separation of the invasion zones, thereby creating two or more separate invasion zones in any one of TMM devices 10a-10g. The separate invasion zones of TMM device 10a and / or TMM device 10b may, for example, include different ECM materials and / or other cell types within each invasion zone, thereby allowing the impact of one invasion zone compared to another to be analyzed by analyzing the migration or invasion pattern or distance (from sample zone to invasion zone) of cells of interest.
[0121] In another embodiment, cells within TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g may be visualized using microscopy techniques. TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g may be scaled to the size required to accommodate a desired microscope slide (e.g., as shown in Figures 11M-11P and 11G-11I), placed on a microscope slide or other suitable surface, and cells may be visualized in real time and / or after staining, fixing, or labeling using any process or procedure known to those of skill in the art. Also, another embodiment of the TMM device may be fabricated as a baseless slide or multiwell (Figures 20A-20C, 21A, and 21B, respectively), allowing for the introduction of a glass bottom for high resolution microscopy. Any suitable microscopy technique known to those of skill in the art may be used.
[0122] In one embodiment, a tumor cell line of interest is added to the sample core of any of TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g at a concentration of about 5,000 cells / μl to about 150,000 cells / μl, or more preferably, about 40,000 to about 80,000 cells / μl. The tumor cells are allowed to grow, proliferate, and invade until they exit the invasion zone of the TMM device. This process can take 10 to 90 days depending on the type and concentration of ECM mimic introduced into the invasion zone of the TMM device and the metastatic potential of the cells introduced into the TMM device core. After the migrated tumor cells exit the invasion zone, they can be easily isolated by trypsinization. The cell isolation process (also referred to as cell passage through the invasion zone of the device) can be performed one, two, three, four, five, or six times to generate progressively more metastatic subpopulations. Methods for passaging tumor cells are generally known to those of skill in the art.
[0123] In another embodiment, a tumor cell line of interest can be added to a sample core of any of TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g, and the ability of the tumor cell line of interest to migrate or invade the invasion zone can be evaluated over time. This method can distinguish between metastatic and non-metastatic cell lines.
[0124] In another embodiment, the effect of various environmental factors present within the invasion zone of any of TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g on the ability of a target tumor cell to migrate or invade the surrounding area is analyzed.
[0125] In another embodiment, anti-cancer drugs or other test drugs or compounds can be evaluated by analyzing their effect on the ability of tumor cells to migrate or invade the invasion zone of any of TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g in the presence of the test drug or compound. The concentration of the test drug or compound can include any concentration known to one of skill in the art. The concentration range of the test drug or compound provided to tumor cells in any of TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g can include the approximate concentration of the test drug or compound effective to slow tumor cell migration.
[0126] Stable radial gradients of hypoxia, acidosis, and nutrients are established from the core of any of the TMM devices 10a-10h, 110a, 110d, 110e, 110f, and 110g of the present disclosure. Thus, in another embodiment, cells can be uniformly introduced throughout the invasion zone and core of any of the TMM devices 10a-10g, 110a, 110d, 110e, 110f, and 110g of the present disclosure at a concentration of about 5,000 cells / μl to about 150,000 cells / μl, or more preferably about 40,000 to about 80,000 cells / μl, to study their differential metabolic activity under a spectrum of metabolic conditions. EXAMPLES
[0127] Example 1 For example, TMM device 10c was used to compare the migration distances of six different cell lines to evaluate the ability of the TMM device to distinguish between cell lines with different metastatic potential. Individual TMM devices were loaded with 2% collagen as the ECM and the following cell lines: (1) non-metastatic MCF-7 cells, (2) invasive but not metastatic (malignant) HeLa cells, (3) metastatic MDA-MB-231 cells, and (4) metastatic glioblastoma U118 cells, (5) a highly metastatic subpopulation of MDA-MB-231 cells (MDA-TMM2) isolated from a TMM device, and (6) MDA-TMM2 cells isolated from a mouse primary tumor.
[0128] As shown in FIG. 14, the migration distance of cells in each device was measured daily until the cells reached the periphery of the invasion zone, except for MCF-7 and HeLa cells, where monitoring ceased after 19 and 18 days, respectively. Data points in FIG. 14 represent the mean (±SD) of 30 measurements (n=30) for each corresponding time point. Migration distance (μm) in the illustrated embodiment was measured from the outer edge of the sample core to the cell furthest from the edge of the sample core. Thirty distance measurements were made for each device and each time point. The measurements were averaged and standard deviations were calculated. FIG. 14 shows that non-metastatic MCF-7 cells completely fail to invade and show extensive cell death, both via necrosis and apoptosis. HeLa cells, which have been shown to be invasive but not metastatic (malignant tumors), are able to invade very slowly and to a limited depth. On the other hand, MDA-MB-231 and U118, both highly metastatic cell lines, show clear and sustained invasion. Furthermore, MDA-TMM2, MDA-MB-231 cells that were introduced into the TMM device core at 10a and allowed to pass through and exit the invasion zone of the device twice, were shown to have a higher metastatic potential than their parental cell line. Furthermore, MDA TMM2 cells were introduced into a nude mouse model, and after 9 weeks, the primary tumor was surgically removed, allowing for reisolation of the MDA TMM2 cells. The reisolated cells were then reintroduced into the core of the TMM device and showed identical invasion capabilities as MDA TMM2 cells that were not introduced into the animal model. Thus, cells that passed through the device are stably modified compared to the parental cell line.
[0129] The data show that the disclosed device and in vitro method can distinguish between benign, malignant, and metastatic cells. This experiment also shows that the disclosed device and in vitro method allow for the introduction and testing of the invasive potential of any human tumor cell line or primary tumor cell mesh from a biopsy in a controlled and reproducible manner.
[0130] Example 2 The migration distance of HeLa or MDA-MB-231 cells was co-cultured with NIH / 3T3 mouse embryonic fibroblasts using the TMM device 10e. HeLa MDA-MB-231 cells expressing GFP were visualized using fluorescence after 3 days of culture. NIH / 3T3 mouse embryonic fibroblasts were stained with Ruby in the invasion zone. Figures 15A-F show the migration of HeLa MDA-MB-231 cells from within the sample core of the TMM device labeled with GFP, and the migration of NIH / 3T3 mouse embryonic fibroblasts stained with Ruby in the invasion zone, respectively. In particular, Figure 15A shows HeLa cells (1) within the sample core of the TMM device labeled with GFP, and NIH / 3T3 mouse embryonic fibroblasts stained with Ruby in the invasion zone (2). Figure 15B and Figure 15F show MDA-MB-231 cells in the sample core of the TMM device labeled with GFP (1) and NIH / 3T3 mouse embryonic fibroblasts stained with Ruby in the invasion zone (2). Specifically, Figure 15B shows that using the same sample, 10e can be used to introduce NIH / 3T3 mouse embryonic fibroblasts into half of the invasion zone to assess how cells behave in the presence or absence of fibroblasts in the invasion zone of the device. Furthermore, Hela cells expressing GFP were introduced into the core of the TMM device 10e and co-cultured with normal NIH / 3T3 mouse embryonic fibroblasts introduced in the invasion zone of the device for 8 days. Figure 25 shows the conversion of normal NIH / 3T3 to cancer-associated fibroblasts (1) (CAFs) after 8 days by immunofluorescence staining with mouse monoclonal anti-smooth muscle actin antibody, the most widely accepted marker for CAFs, and secondary anti-mouse 647 (2) antibody. Overall, these experiments therefore demonstrate that the disclosed devices and methods allow for the introduction of multiple cell types into the invasion zone and for them to be co-cultured with cancer cells in order to study their role in metastasis.
[0131] Example 3 FIG. 23 and FIG. 16C show an embodiment in which MDA-MB-231 cells (1) were introduced homogeneously within the invasion zone of a TMM device to evaluate the microenvironment and gradients generated by the disclosed device and method. Specifically, FIG. 23 shows a pH gradient formed within the device after 24 hours using 5-(and-6)-carboxy SNARF®-1, acetoxymethyl ester, acetate (Invitrogen). This shows that the core of the device and the initial region of the invasion zone are highly acidic with a pH of about 6.2, which is characteristic of almost all solid tumors in vivo. FIG. 23 also shows that the pH increases linearly within the invasion zone until it reaches the end of the invasion zone at a pH of about 7.2, which is close to physiological conditions in vivo. Additionally, FIG. 16C shows an oxygen gradient generated within the device after 24 hours using Image-iT® red hypoxia reagent (Invitrogen). FIG. 16C shows strong red signal from MDA-MB-231 cells at the core and beginning of the invasion zone, indicating a hypoxic environment, while the red signal is reduced and then lost from the end of the invasion zone.
[0132] Figures 16A and 16B show evaluation of hypoxic gradients generated after 20 days of culture in any of the 10a-10g, 110a, 110d, 110e, 110f, and 110g devices of the present disclosure to demonstrate that the gradients within the TMM devices are maintained over time. Metastatic MDA-MB-231 cells expressing GFP were added to the sample core of the device, and after 20 days, the cells were analyzed for expression of HIF-1a, a marker indicative of hypoxia, via immunofluorescence. Figure 16A shows a maximum intensity projection of MDA-MB-231 cell migration within the device after sustaining in culture for 20 days. Figure 16B shows immunofluorescence images (rows 1-5) of MDA-MB-231 cells taken from the sample core, along with four concentric regions of the invasion zone. The numbered rings shown in Figure 16A correspond to the numbered rows of the immunofluorescence images in Figure 16B. This experiment shows a similar oxygen gradient to the Image-iT® red hypoxic reagent, thus suggesting that the gradient generated de novo with the disclosed device is maintained over long periods of time.
[0133] For example, using TMM device 10c, three cell lines were used to evaluate the formation of necrotic cores. Cell lines containing 2% collagen as ECM, (1) non-metastatic MCF-7 cells, (2) invasive but not metastatic (malignant) HeLa cells, and (3) metastatic MDA-MB-231 cells were deposited into individual TMM devices. Specifically, 2 days after cell introduction within the core of the TMM device, the formation of central necrosis was evaluated in real time using a necrosis / apoptosis assay kit (Abcam, ab176749). Figure 22 shows that all three cell lines form extensive necrosis (3) and apoptosis (2) within the central region of the core sample, which is a common feature of almost all solid tumors. In addition, a secondary ring is formed by MCF-7 cells with healthy cells (1), another feature of solid tumors in vivo, while healthy cells of metastatic MDA-MB-231 cells can also be observed within the invasion zone.
[0134] 17 shows another example of time-lapse imaging of de novo gradients of cell culture medium growth toward the center of TMM devices 10a-10g, 110a, 110d, 110e, 110f, and 110g over a 30 minute period. The cell culture medium is visible by staining with fluorescein isothiocyanate ("FITC").
[0135] FIG. 18 shows, in a further example, a depth-encoded reconstruction of cellular 3D migration from a sample core to the invasion zone of TMM devices 10a-10g, 110a, 110d, 110e, 110f, and 110g. Layer 1 represents the lower limit of TMM devices 10a-10g, 110a, 110d, 110e, 110f, and 110g, and layer 2 represents the upper limit of devices 10a-10g, 110a, 110d, 110e, 110f, and 110g. Arrows indicate the direction of migrating cancer cells through the invasion zone and ECM mimic. Thus, FIG. 18 shows that the disclosed device and in vitro method generate a 3D environment for transporting cancer cells.
[0136] Thus, these experiments demonstrate that the disclosed devices and methods are capable of recapitulating and maintaining the in vivo tumor microenvironment in vitro.
[0137] Example 4 MDA-MB-231 metastatic cancer cells expressing GFP containing 2% collagen as ECM in both the core and invasion zone were deposited in the core of the TMM device 10e and the device was immersed in cell culture medium. The device was then placed in an incubator until a small subset of cells had passed and exited from the invasion zone. These cells showing faster invasion and exit from the device were isolated and designated MDA TMM1 cells. MDA TMM1 cells were then reintroduced into the core of the TMM device 10e and the procedure was repeated, and MDA TMM2 was isolated and compared to the parental cell line.
[0138] Specifically, FIG. 14 shows that MDA TMM2 cells have higher invasiveness compared to their parental cell lines in vitro. In addition, FIG. 26A-C show that MDA TMM2 cell lines show elevated expression of both c-Myc oncoprotein and phosphorylated FAK (pFAK), which have been shown to promote tumor aggressiveness and metastasis. Furthermore, MDA TMMe2 cell lines show reduced expression of the tumor suppressor protein p53, a protein that can prevent cancer cells from acquiring additional mutations, the downregulation of which is associated with a worse prognosis in cancer patients. Furthermore, FIG. 24A and FIG. 24B show that animals injected with MDA TMM2 cell lines formed tumors faster and were significantly larger compared to the parental lines. Also, FIG. 24B shows that 80% of animals injected with MDA-TMM2 cell lines formed abdominal metastases, whereas only 20% of animals injected with MDA-MB-231 cell lines formed abdominal metastases. Overall, these experiments demonstrate that the disclosed devices and methods apply selective pressure to a core sample, allowing the isolation of cancer cell subpopulations that exhibit greater aggressiveness and metastatic potential both in vitro and in vivo, and that have differential protein expression compared to the initial sample. Isolation of cancer cell subpopulations is a procedure typically performed in vivo, as it is currently difficult to perform with other in vitro devices, typically used for single cell isolation or to isolate cells based on known cell surface markers.
[0139] It should be understood that various changes and modifications to the presently preferred embodiment described herein will be apparent to those skilled in the art. For example, while the lid posts 48 are shown mounted inside the base posts 28, the base posts could instead have a smaller diameter and be mounted inside the lid posts 48. Such changes and modifications can be made without departing from the spirit and scope of the present subject matter and without diminishing its intended advantages. In another example, while the recesses 58 are shown as being provided on the lids 40b and 40d, the recesses 58 could alternatively be provided on the corresponding bases 20b and 20d, with the snap-fit mating projections 38 provided on the lids 40b and 40d. Accordingly, such changes and modifications are intended to be encompassed by the appended claims.
Claims
1. 1. A tumor microenvironment mimicking ("TMM") device configured to limit both nutrient and oxygen uptake, the TMM device comprising: a base including a bottom wall and a plurality of base posts extending from the bottom wall, the base posts being separated from one another to define spaces between the base posts; 1. A tumor microenvironment mimicking ("TMM") device comprising: a lid sized to mate with the base, the lid including a mating wall and a plurality of lid posts extending from the mating wall, the lid posts being separated from one another to form spaces between the base posts, the lid posts being positioned such that when the lid is mated with the base, the lid can variably cover the spaces between the base posts based on a rotational position of the lid relative to the base.
2. The TMM device of claim 1 , wherein the base post extends downwardly from a base, the base is attached to a perimeter wall and a bottom wall, the bottom wall mating with the perimeter wall and the base post.
3. 10. The TMM device of claim 1, wherein the base posts form a base post ring and the lid posts form a lid post ring, the lid post ring being slightly larger or smaller than the base post ring.
4. 4. The TMM device of claim 3, wherein the rings are concentric rings and an inner or outer diameter of the lid post ring is sized to slidably engage the outer or inner diameter, respectively, of the base post ring.
5. The TMM device of claim 1 , wherein the base post and the lid post have at least substantially the same height.
6. 2. The TMM device of claim 1, wherein the base posts are outer base posts, the base further comprising inner core posts extending from the bottom wall, the inner core posts being separated from one another to form spaces between the core posts.
7. The TMM device of claim 6 , wherein the inner core posts form a ring.
8. The TMM device of claim 1 , wherein the lid and the base are configured to releasably secure the rotational position of the lid relative to the base.
9. The TMM device of claim 7 , wherein the lid is configured to be fastened to the base to releasably fix the rotational position of the lid relative to the base.
10. 10. The TMM device of claim 9, wherein the mating wall extends from a sealing flange of the lid and a peripheral wall extends from the bottom wall of the base, the sealing flange being configured to be clamped to the peripheral wall to releasably fix the rotational position of the lid relative to the base.
11. The TMM device of claim 9 , wherein the fastening of the lid to the base includes a plurality of threaded openings, each opening corresponding to a different environmental openness setting.
12. 9. The TMM device of claim 8, wherein one of the lid or base includes a protrusion that snap-fits with one of a plurality of recesses provided by the other of the lid or base to fix the rotational position of the lid relative to the base.
13. The TMM device of claim 12 , wherein each of the recesses corresponds to a different environmental openness setting.
14. The TMM device of claim 1 , wherein the lid defines at least one medium input opening for injecting medium into a cavity formed between the mating wall of the lid and the bottom wall of the base.
15. 15. The TMM device of claim 14, further comprising a core sealer sized to be disposed on the lid, the core sealer including at least one plug that blocks the at least one medium input opening.
16. 2. The TMM device of claim 1, wherein the mating wall extends from a sealing flange of the lid, the sealing flange defining at least one input hole for receiving culture medium and / or oxygen radially outward of the space and the base posts when the lid is mated with the base.
17. 17. The TMM device of claim 16, further comprising at least one media tank sealer for sealing said at least one input hole.
18. 17. The TMM device of claim 16, further comprising at least one partition extending radially from the mating wall and perpendicularly from the sealing flange, the at least one partition blocking a space between the mating wall of the lid and a peripheral wall of the base when the lid is mated with the base.
19. 2. The TMM device of claim 1, wherein the lid includes at least one partition extending from the mating wall, the at least one partition allowing different cells to be placed on the bottom wall of the base, and the at least one partition allowing the different cells to be separated.
20. The TMM device of claim 19 , wherein the at least one partition comprises two aligned partitions that at least substantially bisect the mating wall.
21. 2. The TMM device of claim 1, wherein the lid includes at least one partition extending from the mating wall, the at least one partition allowing different cells to be placed on the bottom wall of the base, and the at least one partition allowing the different cells to be separated.
22. The TMM device of claim 19 , wherein the at least one partition comprises two aligned partitions that at least substantially bisect the mating wall.
23. 1. A method for assessing tumor cell migration, the method comprising: Providing tumor cells in a sample core of the TMM device of claim 1; allowing said tumor cells to grow; and measuring the distance, speed, and number of the tumor cells migrating away from the sample core and into the invasion zone.
24. 1. A method for isolating a heterogeneous cancer cell subpopulation, the method comprising: Providing tumor cells in a sample core of the TMM device of claim 1; allowing the tumor cells to exit the sample core and enter an invasion zone of the TMM device of claim 1; and isolating said tumor cells from said invasive zone.
